1-3 of 3
Richard S Geary, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rationale and Design of a Phase 3 Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Rodney H Falk, MD, Morie A Gertz, MD, Merrill D Benson, MD, Gustavo Buchele, MD PhD, Michela Brambatti, MD MS, Sotirios Tsimikas, MD, Nicholas J Viney, Bsc, Li-Jung Tai, MD PhD, Cecilia Monteiro, MD PhD, Qingqing Yang, MS, Louis St L O'Dea, MB B.Ch. BAO, FRCP, Ewa Karwatowska-Prokopczuk, MD PhD, Eugene Schneider, MD, Richard S Geary, PhD, Brett P Monia, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5764.
https://doi.org/10.1182/blood-2019-129269
Published: 2019
Journal Articles

Transmembrane Protease, Serine 6 (TMPRSS6) Antisense Oligonucleotide (IONIS-TMPRSS6-L RX ) Reduces Plasma Iron Levels of Healthy Volunteers in a Phase 1 Clinical Study

Michael McCaleb, PhD, Jason Lickliter, MBBS, PhD, Andrew Dibble, PhD, Eugene Schneider, MD, Mariam Aghajan, Shuling Guo, Steve Hughes, MD MBA, Richard S Geary, PhD, Brett P. Monia, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3634.
https://doi.org/10.1182/blood-2018-99-115339
Published: 2018
Journal Articles

Pharmacokinetics and Pharmacodynamics of Ionis-FXI Rx , an Antisense Inhibitor of Factor XI, in Patients with End-Stage Renal Disease on Hemodialysis

Claudette Bethune, PhD, Michael Walsh, MD, PhD, Bill Jung, PhD, Rosie Yu, PhD, Richard S Geary, PhD, Sanjay Bhanot, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1116.
https://doi.org/10.1182/blood.V130.Suppl_1.1116.1116
Published: 2017